AMPH - Amphastar Pharmaceuticals, Inc.
19.96
0.130 0.651%
Share volume: 594,582
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$19.83
0.13
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-09-2024 | 11-07-2024 | 03-03-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 1.574 B | 1.492 B | 1.545 B | 1.577 B | 1.626 B | 1.615 B | 1.666 B | 1.629 B | |
| Current Assets | 555.078 M | 482.645 M | 545.949 M | 534.071 M | 587.961 M | 580.830 M | 639.470 M | 636.016 M | |
| Inventories | 115.494 M | 122.411 M | 130.316 M | 153.741 M | 185.476 M | 191.731 M | 185.932 M | 176.890 M | |
| Other Current Assets | 784.000 K | 667.000 K | 5.349 M | 1.747 M | 758.000 K | 1.603 M | 2.065 M | 17.167 M | |
| Short Term Investments | 88.407 M | 28.156 M | 58.375 M | 70.036 M | 54.101 M | 44.062 M | 59.944 M | 112.635 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 201.148 M | 189.619 M | 192.116 M | 151.609 M | 182.782 M | 187.689 M | 216.265 M | 170.177 M | |
| Total Non-current Assets | 15.163 M | 9.944 M | 0.000 | 10.996 M | 5.913 M | 2.047 M | 0.000 | 0.000 | |
| Property Plant Equipment | 288.523 M | 287.999 M | 295.384 M | 297.345 M | 307.602 M | 310.239 M | 308.689 M | 310.567 M | |
| Other Assets | 730.716 M | 720.878 M | 703.845 M | 746.054 M | 730.713 M | 724.264 M | 718.063 M | 682.716 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.574 B | 1.492 B | 1.545 B | 1.577 B | 1.626 B | 1.615 B | 1.666 B | 1.629 B | |
| Total liabilities | 901.961 M | 778.176 M | 817.500 M | 845.172 M | 874.993 M | 857.851 M | 889.476 M | 840.494 M | |
| Total current liabilities | 255.169 M | 136.971 M | 159.010 M | 173.759 M | 199.052 M | 176.407 M | 205.227 M | 158.156 M | |
| Accounts Payable | 116.697 M | 131.212 M | 153.268 M | 157.057 M | 175.940 M | 166.552 M | 190.844 M | 148.348 M | |
| Other liabilities | 46.720 M | 48.286 M | 55.978 M | 62.826 M | 65.126 M | 66.760 M | 68.710 M | 67.663 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 594.006 M | 586.853 M | 596.446 M | 601.630 M | 603.858 M | 607.727 M | 608.582 M | 608.749 M | |
| Other liabilities | 46.720 M | 48.286 M | 55.978 M | 62.826 M | 65.126 M | 66.760 M | 68.710 M | 67.663 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 672.356 M | 713.346 M | 727.678 M | 732.298 M | 751.283 M | 757.482 M | 776.746 M | 788.805 M | |
| Common stock | 476.078 M | 487.577 M | 496.433 M | 505.406 M | 509.114 M | 520.587 M | 527.221 M | 535.386 M | |
| Retained earnings | 452.445 M | 490.394 M | 530.823 M | 568.787 M | 594.071 M | 625.102 M | 642.451 M | 666.881 M |